Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.23 EUR | -0.27% | -3.49% | -42.81% |
Dec. 03 | BAYER AG : JP Morgan reaffirms its Neutral rating | ZD |
Dec. 03 | ZBD Pharma Gets China Approval for Antibacterial Injection | MT |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
-696.5x | 0.5697 | 7.03x | 1.1x | 5.07x | 8.17x | +0.56% | 19.88B | ||
62.64x | 41.94 | 0.52x | 16.24x | 45.97x | 50.77x | +0.65% | 720B | ||
34.37x | 24.18 | 1.62x | 12.03x | 24.3x | 27.11x | +1.45% | 483B | ||
22.57x | 5.146 | -0.45x | 4.33x | 12.62x | 14.25x | +3.15% | 373B | ||
38.25x | 38.02 | 0.51x | 6.76x | 14.65x | 15.2x | +3.43% | 321B | ||
14.16x | 5.421 | 0x | 4.33x | 10.2x | 11.68x | +3.03% | 255B | ||
15.46x | 5.669 | 0.98x | 3.64x | 9.51x | 10.62x | +3.84% | 232B | ||
19.13x | 4.682 | -0.82x | 4.44x | 11.2x | 11.8x | +3.59% | 210B | ||
24.58x | 4.983 | 0.58x | 4.31x | 13.46x | 13.44x | +2.33% | 207B | ||
30.78x | 21.99 | -1.11x | 5.97x | 10.38x | 13.39x | +3.26% | 149B | ||
16.3x | 1.652 | 0.05x | 3.25x | 8.44x | 10x | +6.52% | 146B | ||
-18.65x | 7.041 | 0.1x | 3.36x | 29.21x | 33.95x | +3.98% | 122B | ||
16.79x | 1.499 | 0.63x | 2.62x | 8.98x | 9.7x | +4.17% | 121B | ||
646.5x | 6.040 | -6.68x | 4.76x | 12.59x | 16.42x | +3.26% | 117B | ||
28.71x | 5.858 | 1.76x | 8.69x | 17.64x | 19.36x | +1.34% | 72.86B | ||
14.92x | 3.706 | -0.57x | 2.2x | 6.7x | 7.61x | +4.50% | 69.22B | ||
41.13x | 5.511 | 3.13x | 4.6x | 25.4x | 32.88x | +1.23% | 61.73B | ||
53.19x | 7.122 | 1.35x | 10.98x | 42.83x | 45.89x | +0.47% | 44.11B | ||
57.03x | 0.9035 | -2.64x | 2.39x | 10.07x | 34.38x | +4.76% | 43.77B | ||
Average | 22.18x | 10.1 | 0.31x | 5.58x | 16.80x | 20.35x | +2.92% | 198.27B | |
Weighted average by Cap. | 47.21x | 17.89 | 0.22x | 7.80x | 20.93x | 23.59x | +2.62% |
- Stock Market
- Equities
- BAYN Stock
- Sector Bayer AG
- Sector valuations